[PDF][PDF] Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial
Y Li, Z Xie, W Lin, W Cai, C Wen, Y Guan, X Mo… - Med, 2020 - cell.com
Background Antiviral therapies against the novel coronavirus SARS-CoV-2, which has
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.
Y Li, Z Xie, W Lin, W Cai, C Wen, Y Guan, X Mo… - Med (New York …, 2020 - europepmc.org
Background Antiviral therapies against the novel coronavirus SARS-CoV-2, which has
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
[引用][C] Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
Y Li, Z Xie, W Lin, W Cai, C Wen, Y Guan, X Mo… - Med, 2020 - cir.nii.ac.jp
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate
COVID-19: An Exploratory Randomized Controlled Trial | CiNii Research CiNii 国立情報学 …
COVID-19: An Exploratory Randomized Controlled Trial | CiNii Research CiNii 国立情報学 …
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
Y Li, Z Xie, W Lin, W Cai, C Wen, Y Guan, X Mo… - 2020 - pubmed.ncbi.nlm.nih.gov
Background Antiviral therapies against the novel coronavirus SARS-CoV-2, which has
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
[HTML][HTML] Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
Y Li, Z Xie, W Lin, W Cai, C Wen, Y Guan, X Mo… - Med (New York …, 2020 - ncbi.nlm.nih.gov
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate
COVID-19: An Exploratory Randomized Controlled Trial - PMC Back to Top Skip to main content …
COVID-19: An Exploratory Randomized Controlled Trial - PMC Back to Top Skip to main content …
[HTML][HTML] Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
Y Li, Z Xie, W Lin, W Cai, C Wen, Y Guan, X Mo… - Med, 2020 - Elsevier
Background Antiviral therapies against the novel coronavirus SARS-CoV-2, which has
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
[PDF][PDF] Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial
Y Li, Z Xie, W Lin, W Cai, C Wen, Y Guan, X Mo… - umfcs.u-bordeaux.fr
Background: Antiviral therapies against the novel coronavirus SARS-CoV-2, which has
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …